Tech Company Financing Transactions
Amalgam Rx Funding Round
On 10/6/2023, Amalgam Rx raised Series B funding from CVS Health Ventures.
Transaction Overview
Company Name
Announced On
10/6/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its business reach. The investment supports the scaling of Amalgam's EHR-integrated clinical decision support platform to provide actionable information for health care providers (HCPs) for use at the point of care.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
1007 North Orange Street 400
Wilmington, DE 19801
USA
Wilmington, DE 19801
USA
Phone
Undisclosed
Website
Email Address
Overview
At Amalgam, we've never been afraid to be the first. Our leadership team has more than 15 years of experience developing, clearing, and deploying groundbreaking patient support programs and SaMD Digital Therapeutics that transform care delivery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Sysko
Chief Financial Officer
Jennifer Main
Chief Technical Officer
Matti Prasad
Browse more venture capital transactions:
Prev: 10/6/2023: Ellis Brooklyn venture capital transaction
Next: 10/6/2023: Machina Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs